Smith & Nephew SNATS, Inc. (SNN) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) from a hold rating to a buy rating in a research note issued to investors on Tuesday. Zacks Investment Research currently has $38.00 price objective on the medical equipment provider’s stock.

According to Zacks, “Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physician advantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment to deliver new levels of healing to patients throughout the world “

Separately, BidaskClub upgraded shares of Smith & Nephew SNATS from a buy rating to a strong-buy rating in a research report on Friday, June 23rd. Six investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of Buy and a consensus price target of $38.00.

Smith & Nephew SNATS (NYSE SNN) opened at 35.06 on Tuesday. Smith & Nephew SNATS has a 52-week low of $26.97 and a 52-week high of $35.82. The stock has a market capitalization of $15.33 billion, a P/E ratio of 19.97 and a beta of 0.77. The stock has a 50 day moving average of $34.91 and a 200 day moving average of $31.97.

WARNING: “Smith & Nephew SNATS, Inc. (SNN) Stock Rating Upgraded by Zacks Investment Research” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/2722277/smith-nephew-snats-inc-snn-stock-rating-upgraded-by-zacks-investment-research.html.

Hedge funds have recently bought and sold shares of the company. BB&T Corp boosted its stake in shares of Smith & Nephew SNATS by 4.3% in the first quarter. BB&T Corp now owns 79,804 shares of the medical equipment provider’s stock worth $2,468,000 after buying an additional 3,299 shares during the period. Wrapmanager Inc. boosted its stake in shares of Smith & Nephew SNATS by 12.2% in the first quarter. Wrapmanager Inc. now owns 9,971 shares of the medical equipment provider’s stock worth $308,000 after buying an additional 1,082 shares during the period. Nuance Investments LLC boosted its stake in shares of Smith & Nephew SNATS by 6.5% in the first quarter. Nuance Investments LLC now owns 2,147,255 shares of the medical equipment provider’s stock worth $66,415,000 after buying an additional 131,388 shares during the period. Eqis Capital Management Inc. boosted its stake in shares of Smith & Nephew SNATS by 35.6% in the first quarter. Eqis Capital Management Inc. now owns 39,587 shares of the medical equipment provider’s stock worth $1,224,000 after buying an additional 10,394 shares during the period. Finally, Bbva Compass Bancshares Inc. boosted its stake in shares of Smith & Nephew SNATS by 20.3% in the first quarter. Bbva Compass Bancshares Inc. now owns 40,733 shares of the medical equipment provider’s stock worth $1,260,000 after buying an additional 6,865 shares during the period. 7.09% of the stock is owned by institutional investors and hedge funds.

About Smith & Nephew SNATS

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Get a free copy of the Zacks research report on Smith & Nephew SNATS (SNN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.